Skip to content
OpenCapital
Get started

Clarivate CLVT Life Sciences & Healthcare — Restructuring costs

Other segment segments

Academia & Government Group
$4.8M-61.0%
Intellectual Property Group
$4.1M-36.9%

Similar metrics at other companies

Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Restructuring and other costs
$9M—
Revvity logo
RVTYLife Sciences — Restructuring and Other Costs (Income)
$3.23M+27.7%
Haemonetics logo
HAECorporate — Restructuring related costs
$37K-97.5%
International Flavors & Fragrances logo
IFFHealth & Biosciences — Restructuring Charges
$2M-33.3%
Gates Industrial Corporation logo
GTESRestructuring expenses
$700K-56.3%
Haemonetics logo
HAEHospital — Restructuring related costs
$0-100%

Other financials

Income statement

See full
Revenue$585.5M-1.4%
Gross profit$393.4M+1.7%
Operating income$30.2M+245%
Net income-$40.2M+61.3%
EPS (diluted)-$0.06+60.0%

Balance sheet

See full
Cash & equivalents$242.2M-31.6%
Total debt$4.4B-5.7%
Total equity$4.8B-4.7%
Total assets$10.9B-4.9%

Cash flow

See full
Operating cash flow$134.7M-21.3%
CapEx$55.8M-8.4%
Free cash flow$78.9M-28.5%

Valuation

See full
Market cap$1.28B-55.2%
Enterprise value$5.45B-24.2%
P/S0.5×-0.6×

Profitability

See full
Gross margin66.5%+0.5pp
Operating margin5%+2.9pp
Net margin-5.7%-2.5pp
FCF margin13.6%-0.4pp

Returns & leverage

See full
Return on equity-2.9%-1.2pp
Debt / equity0.9×0.0×
Current ratio0.8×0.0×

Where this comes from

Reported directly by Clarivate in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCharges.

The official record: Clarivate’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Clarivate's life sciences & healthcare — restructuring costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Clarivate's life sciences & healthcare — restructuring costs?
Clarivate (CLVT) reported life sciences & healthcare — restructuring costs of $3.1M in Q1 2026.
How has Clarivate's life sciences & healthcare — restructuring costs changed year-over-year?
Clarivate's life sciences & healthcare — restructuring costs decreased by 47.5% year-over-year, from $5.9M to $3.1M.
What is the long-term trend for Clarivate's life sciences & healthcare — restructuring costs?
Over 3 years (2021 to 2025), Clarivate's life sciences & healthcare — restructuring costs has grown at a -21.2% compound annual growth rate (CAGR), from $28.2M to $13.8M.
What does life sciences & healthcare — restructuring costs mean?
This metric captures the expenses incurred by the Life Sciences & Healthcare segment related to organizational realignment, workforce reductions, or business process optimization. Monitoring these costs helps investors assess the impact of strategic pivots and the efficiency of operational transformation initiatives within the segment.